Report Overview

The South Korea chronic obstructive pulmonary disease market size stood at around USD 10.5 millions in 2019 and is projected to reach xx millions by 2028, exhibiting a CAGR of around xx during the forecast period.

Chronic obstructive pulmonary disease (COPD) is a common chronic respiratory disease characterized by persistent respiratory symptoms such as cough, sputum, dyspnoea, and irreversible airway obstruction.COPD is known to be caused by smoking, occupational exposure, air pollution, etc and it is known that small airway lung disease and lung parenchymal destruction caused by this cause airflow restrictions and various clinical symptoms.

The prevalence of chronic obstructive pulmonary disease (COPD) in Korea between 2007 and 2015 was about 13%. COPD was the third leading cause of death in 2016 worldwide, claiming 3 million lives and ranked 8th in causes of death in Korea in 2018.



Market Drivers

The rise in the elderly population and increasing prevalence of COPD positively affect the market growth. COPD is caused by the interaction of personal factors such as lung growth disorder and genetic predisposition, behavioural factors such as smoking and environmental factors such as indoor air pollution and fine dust. According to a study by Kim Y et al; the prevalence of COPD in males was more among ex-smokers and current smokers than among non-smokers. There is a continuous increase in cases because of these factors, and this trend is expected to continue in the future.